semaglutide approved for mash 🔴We now have two FDA-approved drugs MASLD/MASH: 🔸 Resmetirom (oral, THR-β agonist) 🔹 (weekly SC, GLP-1 RA) side-by-side comparison, courtesy of @rabataller #MASLD #MASH #FattyLiver @_ILTS_ @EASLedu @AASLDtweets @novonordisk Novo Nordisk's Wegovy gets accelerated

Completion of the trials main phase is expected in September 2025, and the 52-week extension (in which participants and investigators remain blinded to treatment assignment) will continue to October 2026

Reduced appetite and food noise

The pharmacy chain was barred by the FTC from using face surveillance after incidents in several cities, including Philadelphia

Remove after 4 hours or the next morning if used overnigVersatile Use for Multiple Activities: Perfect for working, reading, sleeping, and sports

A Clinical Hypothesis on Viral Gastroenteritis and Endogenous Incretin Response A curious observation comes up now and then in clinic: a patient with a viral GI illnesstypically marked by nausea, loss of appetite, and sometimes transient weight lossdescribes symptoms eerily similar to what we see